Search research articles
Contact Us
Filters
Showing results (351-360 of 362) with videos related to
Page
of 37
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2025
A Complex FGF14 (TTC)/(TGC) Repeat Expansion in Parkinson's Disease
Xiaosheng Zheng, Zhidong Cen, Xinhui Chen, et al.
Age and Ageing
|
May 21, 2026
Frailty and intrinsic capacity: integrating complementary concepts to promote healthy ageing and transformation of care
Matteo Cesari, Marco Canevelli, Jotheeswaran Amuthavalli Thiyagarajan, et al.
Nature Genetics
|
June 9, 2016
Identification of TMEM230 mutations in familial Parkinson's disease
Han-Xiang Deng, Yong Shi, Yi Yang, et al.
Nature Communications
|
June 17, 2022
Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
Zhenhua Liu, Nannan Yang, Jie Dong, et al.
Journal of Alzheimer'S Disease : JAD
|
January 14, 2026
Prevalence of subjective cognitive decline with Alzheimer's disease neuropathology in a community-based Chinese cohort
Jing Yuan, Yaoda Hu, Feng Feng, et al.
NPJ Parkinson'S Disease
|
March 28, 2026
The genetic spectrum of LRRK2 variants in Parkinson's disease: findings from a large Chinese cohort
Juan Wan, Hongxu Pan, Dong Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 2018
Coding mutations in <i>NUS1</i> contribute to Parkinson's disease
Ji-Feng Guo, Lu Zhang, Kai Li, et al.
NPJ Parkinson'S Disease
|
February 9, 2023
Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson's disease in Chinese population
Hongxu Pan, Zhenhua Liu, Jinghong Ma, et al.
Brain : a Journal of Neurology
|
July 3, 2020
The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population
Yuwen Zhao, Lixia Qin, Hongxu Pan, et al.
Alzheimer'S Research & Therapy
|
March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia
Shifu Xiao, Piu Chan, Tao Wang, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 362) with videos related to
Sort By:
Page
of 37
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2025
A Complex FGF14 (TTC)/(TGC) Repeat Expansion in Parkinson's Disease
Xiaosheng Zheng, Zhidong Cen, Xinhui Chen, et al.
Age and Ageing
|
May 21, 2026
Frailty and intrinsic capacity: integrating complementary concepts to promote healthy ageing and transformation of care
Matteo Cesari, Marco Canevelli, Jotheeswaran Amuthavalli Thiyagarajan, et al.
Nature Genetics
|
June 9, 2016
Identification of TMEM230 mutations in familial Parkinson's disease
Han-Xiang Deng, Yong Shi, Yi Yang, et al.
Nature Communications
|
June 17, 2022
Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
Zhenhua Liu, Nannan Yang, Jie Dong, et al.
Journal of Alzheimer'S Disease : JAD
|
January 14, 2026
Prevalence of subjective cognitive decline with Alzheimer's disease neuropathology in a community-based Chinese cohort
Jing Yuan, Yaoda Hu, Feng Feng, et al.
NPJ Parkinson'S Disease
|
March 28, 2026
The genetic spectrum of LRRK2 variants in Parkinson's disease: findings from a large Chinese cohort
Juan Wan, Hongxu Pan, Dong Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 2018
Coding mutations in <i>NUS1</i> contribute to Parkinson's disease
Ji-Feng Guo, Lu Zhang, Kai Li, et al.
NPJ Parkinson'S Disease
|
February 9, 2023
Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson's disease in Chinese population
Hongxu Pan, Zhenhua Liu, Jinghong Ma, et al.
Brain : a Journal of Neurology
|
July 3, 2020
The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population
Yuwen Zhao, Lixia Qin, Hongxu Pan, et al.
Alzheimer'S Research & Therapy
|
March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia
Shifu Xiao, Piu Chan, Tao Wang, et al.
Page
of 37